Corteva price target raised to $62 from $60 at Oppenheimer

Oppenheimer raised the firm’s price target on Corteva to $62 from $60 and keeps an Outperform rating on the shares. Corteva reported better than expected Q4 results and outlined a path toward achieving 2025 EBITDA margin targets built largely on levers within its control, the analyst tells investors in a research note. Beyond 2025, the firm believes the value creation framework offers a longer-tail opportunity for compounding earnings growth driven by self-help that has focused less on cost-cutting.